Skip to main content
Top
Published in: BMC Cancer 1/2006

Open Access 01-12-2006 | Research article

Thyroid cancer in Luxembourg: a national population-based data report (1983–1999)

Authors: René Scheiden, Marc Keipes, Carlo Bock, Walter Dippel, Nelly Kieffer, Catherine Capesius

Published in: BMC Cancer | Issue 1/2006

Login to get access

Abstract

Background

Twenty years after the nuclear accident in Chernobyl (Eastern Europe), there is still a controversial debate concerning a possible effect of the radioactive iodines, especially I-131, on the increase of thyroid carcinomas (TCs) in Western Europe. Time trends in incidence rates of TC in Luxembourg in comparison with other European countries and its descriptive epidemiology were investigated.

Methods

The population-based data of the national Morphologic Tumour Registry collecting new thyroid cancers diagnosed between 1983 and 1999 at a nation-wide level in the central division of pathology were reviewed and focused on incidence rates of TC. Data from 1990 to 1999 were used to evaluate the distribution by gender, age, histological type, tumour size and the outcome.

Results

Out of 310 new thyroid carcinomas diagnosed between 1990 and 1999, 304 differentiated carcinomas (A: 80% papillary; B: 14.5% follicular; C: 3.5% medullary) and 6 anaplastic/undifferentiated TCs (D: 2%) were evaluated. The M/F-ratio was 1:3.2, the mean age 48.3 years (range: 13–92). The overall age-standardized (world population) incidence rates over the two 5-year periods 1990–1994 and 1995–1999 increased from 7.4 per 100,000 to 10.1 per 100,000 in females, from 2.3 per 100,000 to 3.6 per 100,000 in males. Only 3 patients were children or adolescents (1%), the majority of the patients (50%) were between 45 and 69 years of age. The percentage of microcarcinomas (<1 cm) was A: 46.4%, (115/248); B: 13.3%, (6/45); C: 27.3%, (3/11). The unexpected increase of TCs in 1997 was mainly due to the rise in the number of microcarcinomas. The observed 5-year survival rates for both genders were A: 96.0+/-2%; B: 88.9%; C: 90.9%; D: 0%. Prognosis was good in younger patients, worse in males and elderly, and extremely poor for undifferentiated TCs.

Conclusion

The increasing incidence rates of TC, especially of the papillary type, seem mainly due to a rise in diagnosed microcarcinomas due to some extent to a change in histologic criteria and to more efficient diagnostic tools. This rise appears to be independent of the number of surgical treatments, the immigration rate, and the Chernobyl fallout as the incidence of TC in children remained stable.
Appendix
Available only for authorised users
Literature
1.
go back to reference Abelin T, Averkin JI, Egger M, Egloff B, Furmanchuk AW, Gurtner F, Korotkevich JA, Marx A, Matveyenko II, Okeanov AE, Ruchti Ch, Schaeppi W: Thyroid cancer in Belarus post-Chernobyl: Improved detection or increase incidence. Soz Präventivmed. 1994, 39: 189-197. 10.1007/BF01309218.CrossRefPubMed Abelin T, Averkin JI, Egger M, Egloff B, Furmanchuk AW, Gurtner F, Korotkevich JA, Marx A, Matveyenko II, Okeanov AE, Ruchti Ch, Schaeppi W: Thyroid cancer in Belarus post-Chernobyl: Improved detection or increase incidence. Soz Präventivmed. 1994, 39: 189-197. 10.1007/BF01309218.CrossRefPubMed
2.
go back to reference Verger P, Catelinois O, Tirmarche M, Cherie-Challine L, Pirard P, Colonna M, Hubert P: Thyroid cancers in France and the Chernobyl accident: risk assessment and recommendations for improving epidemiological knowledge. Health Phys. 2003, 85 (3): 323-9. 10.1097/00004032-200309000-00008.CrossRefPubMed Verger P, Catelinois O, Tirmarche M, Cherie-Challine L, Pirard P, Colonna M, Hubert P: Thyroid cancers in France and the Chernobyl accident: risk assessment and recommendations for improving epidemiological knowledge. Health Phys. 2003, 85 (3): 323-9. 10.1097/00004032-200309000-00008.CrossRefPubMed
3.
go back to reference STATEC: Données démographiques 1983–1999. Luxembourg: Service central de la statistique et des études économiques. 2003, 85 (3): 329-9. STATEC: Données démographiques 1983–1999. Luxembourg: Service central de la statistique et des études économiques. 2003, 85 (3): 329-9.
4.
go back to reference Hedinger Chr, Williams ED, Sobin LH: Histological Typing of Thyroid Tumours. WHO – International Histological Classification of Tumours. 1988, Berlin Heidelberg New York : Springer, 2 Hedinger Chr, Williams ED, Sobin LH: Histological Typing of Thyroid Tumours. WHO – International Histological Classification of Tumours. 1988, Berlin Heidelberg New York : Springer, 2
5.
go back to reference Hermanek P, Sobin LH: TNM classification of malignant tumours, UICC, 2nd revision. 1992, Berlin Heidelberg New York:Springer, 4 Hermanek P, Sobin LH: TNM classification of malignant tumours, UICC, 2nd revision. 1992, Berlin Heidelberg New York:Springer, 4
6.
go back to reference Sobin LH, Wittekind CH: TNM classification of malignant tumours, UICC. 1997, New York, Chichester, Weinheim, Brisbane, Singapore, Toronto: Wiley-Liss, 5 Sobin LH, Wittekind CH: TNM classification of malignant tumours, UICC. 1997, New York, Chichester, Weinheim, Brisbane, Singapore, Toronto: Wiley-Liss, 5
7.
go back to reference Capesius C, Scheiden R, Groff P, Kanz R, Schneider F, Wehenkel Cl: Nouveaux cas de cancer au Luxembourg – Monographies des années 1985 – 1986 – 1987 – 1988 – 1989 – 1990 – 1991 – 1992 – 1993. Luxembourg: Registre Morphologique des Tumeurs au Grand-Duché de Luxembourg. 1991, http://www.cancer-registry.lu Capesius C, Scheiden R, Groff P, Kanz R, Schneider F, Wehenkel Cl: Nouveaux cas de cancer au Luxembourg – Monographies des années 1985 – 1986 – 1987 – 1988 – 1989 – 1990 – 1991 – 1992 – 1993. Luxembourg: Registre Morphologique des Tumeurs au Grand-Duché de Luxembourg. 1991, http://​www.​cancer-registry.​lu
8.
go back to reference Capesius C, Scheiden R, Groff P, Kanz R, Juchem JP, Wehenkel Cl: Nouveaux cas de cancer au Luxembourg – Monographies des années 1983 – 1984 – 1991 – 1995 – 1996 – 1997 – 1998 – 1999. Luxembourg: Registre Morphologique des Tumeurs au Grand-Duché de Luxembourg. 1997, http://www.cancer-registry.lu Capesius C, Scheiden R, Groff P, Kanz R, Juchem JP, Wehenkel Cl: Nouveaux cas de cancer au Luxembourg – Monographies des années 1983 – 1984 – 1991 – 1995 – 1996 – 1997 – 1998 – 1999. Luxembourg: Registre Morphologique des Tumeurs au Grand-Duché de Luxembourg. 1997, http://​www.​cancer-registry.​lu
9.
go back to reference Parkin DM, Muir SL, Whelan SL, Gao YT, Ferlay J, Powell J: Cancer Incidence in Five Continents. 1992, Lyon: IARC Scientific Publications NR120, VI: Parkin DM, Muir SL, Whelan SL, Gao YT, Ferlay J, Powell J: Cancer Incidence in Five Continents. 1992, Lyon: IARC Scientific Publications NR120, VI:
10.
go back to reference Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J: Cancer Incidence in Five Continents. 1997, Lyon: IARC Scientific Publications NR143, VII: Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J: Cancer Incidence in Five Continents. 1997, Lyon: IARC Scientific Publications NR143, VII:
11.
go back to reference Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer Incidence in Five Continents. 2002, Lyon: IARC Scientific Publications NR155, VIII: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer Incidence in Five Continents. 2002, Lyon: IARC Scientific Publications NR155, VIII:
12.
go back to reference Boyle P, Parkin DM: Statistical methods for registries. Cancer registration, principles and methods. Edited by: Jensen OM, Parkin DM, Mac Lennan R, Muir CS, Skeet RG. 1991, Lyon: IARC, 126-158. Boyle P, Parkin DM: Statistical methods for registries. Cancer registration, principles and methods. Edited by: Jensen OM, Parkin DM, Mac Lennan R, Muir CS, Skeet RG. 1991, Lyon: IARC, 126-158.
13.
go back to reference Levi F, Randimbison L, Te VC, La VC: Thyroid cancer in Vaud, Switzerland: an update. Thyroid. 2002, 12 (2): 163-8. 10.1089/105072502753522400.CrossRefPubMed Levi F, Randimbison L, Te VC, La VC: Thyroid cancer in Vaud, Switzerland: an update. Thyroid. 2002, 12 (2): 163-8. 10.1089/105072502753522400.CrossRefPubMed
14.
go back to reference Merhy J, Driscoll HK, Leidy JW, Chertow BS: Increasing incidence and characteristics of differentiated thyroid cancer in Huntington, West Virginia. Thyroid. 2001, 11 (11): 1063-9. 10.1089/105072501753271761.CrossRefPubMed Merhy J, Driscoll HK, Leidy JW, Chertow BS: Increasing incidence and characteristics of differentiated thyroid cancer in Huntington, West Virginia. Thyroid. 2001, 11 (11): 1063-9. 10.1089/105072501753271761.CrossRefPubMed
15.
go back to reference Burgess JR: Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid. 2002, 12 (2): 141-9. 10.1089/105072502753522374.CrossRefPubMed Burgess JR: Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid. 2002, 12 (2): 141-9. 10.1089/105072502753522374.CrossRefPubMed
16.
go back to reference Leenhardt L, Bernier MO, Boin-Pineau MH, Conte Devolx B, Marechaud R, Niccoli-Sire P, Nocaudie M, Orgiazzi J, Schlumberger M, Wemeau JL, Cherie-Challine L, De Vathaire F: Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol. 2004, 150 (2): 133-9. 10.1530/eje.0.1500133.CrossRefPubMed Leenhardt L, Bernier MO, Boin-Pineau MH, Conte Devolx B, Marechaud R, Niccoli-Sire P, Nocaudie M, Orgiazzi J, Schlumberger M, Wemeau JL, Cherie-Challine L, De Vathaire F: Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol. 2004, 150 (2): 133-9. 10.1530/eje.0.1500133.CrossRefPubMed
17.
go back to reference Lundgren CI, Hall P, Ekbom A, Frisell J, Zedenius J, Dickmann PW: Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer. 2003, 106 (4): 569-73. 10.1002/ijc.11275.CrossRefPubMed Lundgren CI, Hall P, Ekbom A, Frisell J, Zedenius J, Dickmann PW: Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer. 2003, 106 (4): 569-73. 10.1002/ijc.11275.CrossRefPubMed
18.
go back to reference Nagataki S, Nystrom E: Epidemiology and primary prevention of thyroid cancer. Thyroid. 2002, 12 (10): 889-96. 10.1089/105072502761016511.CrossRefPubMed Nagataki S, Nystrom E: Epidemiology and primary prevention of thyroid cancer. Thyroid. 2002, 12 (10): 889-96. 10.1089/105072502761016511.CrossRefPubMed
19.
go back to reference Sadetzki S, Calderon-Margalit R, Peretz C, Novikov I, Barchana M, Papa MZ: Second primary breast and thyroid cancers (Israel). Cancer Causes Control. 2003, 14 (4): 367-75. 10.1023/A:1023908509928.CrossRefPubMed Sadetzki S, Calderon-Margalit R, Peretz C, Novikov I, Barchana M, Papa MZ: Second primary breast and thyroid cancers (Israel). Cancer Causes Control. 2003, 14 (4): 367-75. 10.1023/A:1023908509928.CrossRefPubMed
20.
go back to reference Adjadj E, Rubino C, Shamsaldim A, Le MG, Schlumberger M, de Vathaire F: The risk of multiple primary breast and thyroid carcinomas. Cancer. 2003, 98 (6): 1309-17. 10.1002/cncr.11626.CrossRefPubMed Adjadj E, Rubino C, Shamsaldim A, Le MG, Schlumberger M, de Vathaire F: The risk of multiple primary breast and thyroid carcinomas. Cancer. 2003, 98 (6): 1309-17. 10.1002/cncr.11626.CrossRefPubMed
21.
go back to reference Storm HH, Plesko I: Survival of children with thyroid cancer in Europe 1978–1989. Eur J Cancer. 2001, 37 (6): 775-9. 10.1016/S0959-8049(01)00010-7.CrossRefPubMed Storm HH, Plesko I: Survival of children with thyroid cancer in Europe 1978–1989. Eur J Cancer. 2001, 37 (6): 775-9. 10.1016/S0959-8049(01)00010-7.CrossRefPubMed
22.
go back to reference Cotterill SJ, Pearce MS, Parker L: Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident?. Eur J Cancer. 2001, 37 (8): 1020-6. 10.1016/S0959-8049(00)00449-4.CrossRefPubMed Cotterill SJ, Pearce MS, Parker L: Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident?. Eur J Cancer. 2001, 37 (8): 1020-6. 10.1016/S0959-8049(00)00449-4.CrossRefPubMed
23.
go back to reference Liu S, Semenciw R, Ugnat AM, Mao Y: Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer. 2001, 85 (9): 1335-9. 10.1054/bjoc.2001.2061.CrossRefPubMedPubMedCentral Liu S, Semenciw R, Ugnat AM, Mao Y: Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer. 2001, 85 (9): 1335-9. 10.1054/bjoc.2001.2061.CrossRefPubMedPubMedCentral
24.
go back to reference Wakeford R: The cancer epidemiology of radiation. Oncogene. 2004, 23 (38): 6404-28. 10.1038/sj.onc.1207896.CrossRefPubMed Wakeford R: The cancer epidemiology of radiation. Oncogene. 2004, 23 (38): 6404-28. 10.1038/sj.onc.1207896.CrossRefPubMed
25.
go back to reference Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD: Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet. 2005, 365 (9476): 2014-23. 10.1016/S0140-6736(05)66695-0.CrossRefPubMed Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD: Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet. 2005, 365 (9476): 2014-23. 10.1016/S0140-6736(05)66695-0.CrossRefPubMed
26.
go back to reference Sirgurdson AJ, Doody MM, Rao RS, Freedmann DM, Alexander BH, Hauptmann M, Mohan AK, Yoshinaga S, Hill DA, Tarone R, Mabuchi K, Ron E, Linet MS: Cancer incidence in the US radiologic technologists health study, 1983–1998. Cancer. 2003, 97 (12): 3080-9. 10.1002/cncr.11444.CrossRef Sirgurdson AJ, Doody MM, Rao RS, Freedmann DM, Alexander BH, Hauptmann M, Mohan AK, Yoshinaga S, Hill DA, Tarone R, Mabuchi K, Ron E, Linet MS: Cancer incidence in the US radiologic technologists health study, 1983–1998. Cancer. 2003, 97 (12): 3080-9. 10.1002/cncr.11444.CrossRef
27.
go back to reference De Vathaire F, Hardiman C, Shamsaldin A, Campbell S, Grimaud E, Hawkins M, Raquin M, Oberlin O, Diallo I, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Lemerle J, Chavaudra J, Schlumberger M, Bonaiti C: Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med. 1999, 159 (22): 2713-9. 10.1001/archinte.159.22.2713.CrossRefPubMed De Vathaire F, Hardiman C, Shamsaldin A, Campbell S, Grimaud E, Hawkins M, Raquin M, Oberlin O, Diallo I, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Lemerle J, Chavaudra J, Schlumberger M, Bonaiti C: Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med. 1999, 159 (22): 2713-9. 10.1001/archinte.159.22.2713.CrossRefPubMed
28.
go back to reference Szybinski Z, Huszno B, Zemla B, Bandurska-Stankiewicz E, Przybylik-Mazurek E, Nowak W, Cichon S, Buziak-Bereza M, Trofimiuk M, Szybinski P: Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland. J Endocrinol Invest. 2003, 26 (2 Suppl): 63-70.PubMed Szybinski Z, Huszno B, Zemla B, Bandurska-Stankiewicz E, Przybylik-Mazurek E, Nowak W, Cichon S, Buziak-Bereza M, Trofimiuk M, Szybinski P: Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland. J Endocrinol Invest. 2003, 26 (2 Suppl): 63-70.PubMed
29.
go back to reference Feider M: Les conséquences radiologiques de l'accident nucléaire de Tchernobyl au Luxembourg. Ministère de la Santé. Luxembourg. 1986 Feider M: Les conséquences radiologiques de l'accident nucléaire de Tchernobyl au Luxembourg. Ministère de la Santé. Luxembourg. 1986
30.
go back to reference Bhattacharyya N: A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg. 2003, 128 (1): 115-23. 10.1067/mhn.2003.2.CrossRefPubMed Bhattacharyya N: A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol Head Neck Surg. 2003, 128 (1): 115-23. 10.1067/mhn.2003.2.CrossRefPubMed
31.
go back to reference Verkooijen HM, Fioretta G, Pache JC, Franceschi S, Raymond L, Schubert H, Bouchardy C: Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control. 2003, 14 (1): 13-7. 10.1023/A:1022593923603.CrossRefPubMed Verkooijen HM, Fioretta G, Pache JC, Franceschi S, Raymond L, Schubert H, Bouchardy C: Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control. 2003, 14 (1): 13-7. 10.1023/A:1022593923603.CrossRefPubMed
32.
go back to reference Harach HR, Franssila KO, Wasenius VM: Occult papillary carcinoma of the thyroid. Cancer. 1985, 56: 531-538.CrossRefPubMed Harach HR, Franssila KO, Wasenius VM: Occult papillary carcinoma of the thyroid. Cancer. 1985, 56: 531-538.CrossRefPubMed
33.
go back to reference Furmanchuk AW, Roussak N, Ruchti C: Occult thyroid carcinoma in the region of Minsk, Belarus. An autopsy study of 215 patients. Histopathology. 1993, 23: 319-325.CrossRefPubMed Furmanchuk AW, Roussak N, Ruchti C: Occult thyroid carcinoma in the region of Minsk, Belarus. An autopsy study of 215 patients. Histopathology. 1993, 23: 319-325.CrossRefPubMed
34.
go back to reference Cappelli C, Agosti B, Tironi A, Morassi ML, Pelizzari G, Cumetti D, Cerudelli B: Prevalence and aggressiveness of thyroid carcinoma with diameter less than one centimetre in iodine deficiency areas. Minerva Endocrinol. 2002, 27 (2): 65-71.PubMed Cappelli C, Agosti B, Tironi A, Morassi ML, Pelizzari G, Cumetti D, Cerudelli B: Prevalence and aggressiveness of thyroid carcinoma with diameter less than one centimetre in iodine deficiency areas. Minerva Endocrinol. 2002, 27 (2): 65-71.PubMed
35.
go back to reference Chow SM, Law SC, Au SK, Mang O, Yau S, Yuen KT, Lau WH: Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960–2000. Clin Oncol (R Coll Radiol). 2003, 15 (6): 329-36.CrossRef Chow SM, Law SC, Au SK, Mang O, Yau S, Yuen KT, Lau WH: Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960–2000. Clin Oncol (R Coll Radiol). 2003, 15 (6): 329-36.CrossRef
36.
go back to reference Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M, Guizard A, Tretarre B, Buemi AV, Arveux P, Esteve J: Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Euro J Cancer. 2002, 38 (13): 1762-8. 10.1016/S0959-8049(02)00110-7.CrossRef Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M, Guizard A, Tretarre B, Buemi AV, Arveux P, Esteve J: Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Euro J Cancer. 2002, 38 (13): 1762-8. 10.1016/S0959-8049(02)00110-7.CrossRef
37.
go back to reference Rodriguez-Cuevas S, Labastida-Almendaro S, Cortes-Arroyo H, Lopez-Garza J, Barroso-Bravo S: Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population. J Exp Clin Cancer Res. 2002, 21 (1): 79-86.PubMed Rodriguez-Cuevas S, Labastida-Almendaro S, Cortes-Arroyo H, Lopez-Garza J, Barroso-Bravo S: Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population. J Exp Clin Cancer Res. 2002, 21 (1): 79-86.PubMed
38.
go back to reference Kowalski LP, Goncalves Filho J, Pinto CA, Carvalho AL, de Camargo B: Long-term survival rates in young patients with thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003, 129 (7): 746-9. 10.1001/archotol.129.7.746.CrossRefPubMed Kowalski LP, Goncalves Filho J, Pinto CA, Carvalho AL, de Camargo B: Long-term survival rates in young patients with thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003, 129 (7): 746-9. 10.1001/archotol.129.7.746.CrossRefPubMed
Metadata
Title
Thyroid cancer in Luxembourg: a national population-based data report (1983–1999)
Authors
René Scheiden
Marc Keipes
Carlo Bock
Walter Dippel
Nelly Kieffer
Catherine Capesius
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2006
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-6-102

Other articles of this Issue 1/2006

BMC Cancer 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine